{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:12:18Z","timestamp":1784931138878,"version":"3.55.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Based on the available data, it can be assumed that microbiota is an integral part of the human body. The most heavily colonized area of the human body is the gut, with bacterial accumulation ranging from 10<jats:sup>1<\/jats:sup>\u201310<jats:sup>3<\/jats:sup> cells\/g in the upper intestine to 10<jats:sup>11<\/jats:sup>\u201310<jats:sup>12<\/jats:sup> cells\/g in the colon. However, colonization of the gut is not the same throughout, as it was shown that there are differences between the composition of the microbiota in the intestine lumen and in the proximity of the mucus layer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Gut microbiota gradient can be differentially regulated by factors such as obesity and chronic stress. In particular, a high fat diet influences the gut microbial composition. It was also found that chronic stress may cause the development of obesity and thus change the organization of the intestinal barrier. Recent research has shown the significant effect of intestinal microflora on cardiovascular function. Enhanced absorption of bacterial fragments, such as lipopolysaccharide (LPS), promotes the onset of \u201cmetabolic endotoxemia,\u201d which could activate toll-like receptors, which mediates an inflammatory response and in severe cases could cause cardiovascular diseases. It is presumed that the intestinal microbiota, and especially its metabolites (LPS and trimethylamine N-oxide (TMAO)), may play an important role in the pathogenesis of arterial hypertension, atherosclerosis, and heart failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>This review focuses on how gut microbiota can change the morphological and functional activity of the cardiovascular system in the course of obesity and in conditions of chronic stress.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11906-021-01144-7","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T08:32:04Z","timestamp":1621499524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress"],"prefix":"10.1007","volume":"23","author":[{"given":"Piotr","family":"Dubinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9836-9409","authenticated-orcid":false,"given":"Katarzyna","family":"Czarzasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-4447","authenticated-orcid":false,"given":"Agnieszka","family":"Cudnoch-Jedrzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrmicro1152","volume":"3","author":"JK Nicholson","year":"2005","unstructured":"Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol. 2005;3:431\u20138. https:\/\/doi.org\/10.1038\/nrmicro1152.","journal-title":"Nat Rev Microbiol."},{"key":"1144_CR2","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474:1823\u201336. https:\/\/doi.org\/10.1042\/BCJ20160510. This paper contain key information about composition of human gut microbiota.","DOI":"10.1042\/BCJ20160510"},{"key":"1144_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tim.2015.03.002","volume":"23","author":"M Derrien","year":"2015","unstructured":"Derrien M, van Hylckama Vlieg JET. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015;23:354\u201366. https:\/\/doi.org\/10.1016\/j.tim.2015.03.002.","journal-title":"Trends Microbiol."},{"key":"1144_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40168-015-0094-5","volume":"3","author":"JR Marchesi","year":"2015","unstructured":"Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015;3:31. https:\/\/doi.org\/10.1186\/s40168-015-0094-5.","journal-title":"Microbiome."},{"key":"1144_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.embor.7400731","volume":"7","author":"AM O\u2019Hara","year":"2006","unstructured":"O\u2019Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688\u201393. https:\/\/doi.org\/10.1038\/sj.embor.7400731.","journal-title":"EMBO Rep."},{"key":"1144_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/femsre\/fuv010","volume":"39","author":"C Bang","year":"2015","unstructured":"Bang C, Schmitz RA. Archaea associated with human surfaces: not to be underestimated. FEMS Microbiol Rev. 2015;39:631\u201348. https:\/\/doi.org\/10.1093\/femsre\/fuv010.","journal-title":"FEMS Microbiol Rev."},{"key":"1144_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature06245","volume":"449","author":"L Dethlefsen","year":"2007","unstructured":"Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449:811\u20138. https:\/\/doi.org\/10.1038\/nature06245.","journal-title":"Nature."},{"key":"1144_CR8","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635\u20138. https:\/\/doi.org\/10.1126\/science.1110591.","journal-title":"Science."},{"key":"1144_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/microorganisms6030075","volume":"6","author":"SY Geerlings","year":"2018","unstructured":"Geerlings SY, Kostopoulos I, de Vos WM, Belzer C. Akkermansia muciniphila in the human gastrointestinal tract: when, where, and how? Microorganisms. 2018;6:75. https:\/\/doi.org\/10.3390\/microorganisms6030075.","journal-title":"Microorganisms."},{"key":"1144_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59\u201365. https:\/\/doi.org\/10.1038\/nature08821.","journal-title":"Nature."},{"key":"1144_CR11","doi-asserted-by":"publisher","first-page":"e16876","DOI":"10.1371\/journal.pone.0016876","volume":"6","author":"MW van Passel","year":"2011","unstructured":"van Passel MW, Kant R, Zoetendal EG, Plugge CM, Derrien M, Malfatti SA, et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One. 2011;6:e16876. https:\/\/doi.org\/10.1371\/journal.pone.0016876.","journal-title":"PLoS One."},{"key":"1144_CR12","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 de la Cuesta-Zuluaga J, Mueller NT, \u00c1lvarez-Quintero R, Vel\u00e1squez-Mej\u00eda EP, Sierra JA, Corrales-Agudelo V, et al. Higher Fecal Short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. nutrients. Nutrients. 2018;11:51. https:\/\/doi.org\/10.3390\/nu11010051. This ppaer suggest the role of gut microbiom dysbiosis in obesity, hypertension and cardiometabolic disease.","DOI":"10.3390\/nu11010051"},{"key":"1144_CR13","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1128\/aem.68.10.5186-5190.2002","volume":"68","author":"SH Duncan","year":"2002","unstructured":"Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68:5186\u201390. https:\/\/doi.org\/10.1128\/aem.68.10.5186-5190.2002.","journal-title":"Appl Environ Microbiol."},{"key":"1144_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29\u201341. https:\/\/doi.org\/10.1111\/1462-2920.13589.","journal-title":"Environ Microbiol."},{"key":"1144_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3389\/fphar.2018.01082","volume":"9","author":"J Ma","year":"2018","unstructured":"Ma J, Li H. The role of gut microbiota in atherosclerosis and hypertension. Front Pharmacol. 2018;9:1082. https:\/\/doi.org\/10.3389\/fphar.2018.01082.","journal-title":"Front Pharmacol."},{"key":"1144_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11906-020-01125-2","volume":"23","author":"HB Overby","year":"2021","unstructured":"Overby HB, Ferguson JF. Gut microbiota-derived short-chain fatty acids facilitate microbiota:host cross talk and modulate obesity and hypertension. Curr Hypertens Rep. 2021;23:8. https:\/\/doi.org\/10.1007\/s11906-020-01125-2.","journal-title":"Curr Hypertens Rep."},{"key":"1144_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.trsl.2017.06.008","volume":"186","author":"A Kaysen","year":"2017","unstructured":"Kaysen A, Heintz-Buschart A, Muller EEL, Narayanasamy S, Wampach L, Laczny CC, et al. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation. Transl Res. 2017;186:79\u201394. https:\/\/doi.org\/10.1016\/j.trsl.2017.06.008.","journal-title":"Transl Res."},{"key":"1144_CR18","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3:279\u201388. https:\/\/doi.org\/10.4161\/gmic.19625. This paper provides evidences of the role of gut microbiota in pathogenesis of type 2 diabetes and obesity.","DOI":"10.4161\/gmic.19625"},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"e0152126","DOI":"10.1371\/journal.pone.0152126","volume":"11","author":"R Sinha","year":"2016","unstructured":"Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, et al. Fecal microbiota, fecal metabolome, and colorectal cancer interrelations. PLoS One. 2016;11:e0152126. https:\/\/doi.org\/10.1371\/journal.pone.0152126.","journal-title":"PLoS One."},{"key":"1144_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1039\/c5ib00158g","volume":"7","author":"DB Kell","year":"2015","unstructured":"Kell DB, Pretorius E. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr Biol (Camb). 2015;7:1339\u201377. https:\/\/doi.org\/10.1039\/c5ib00158g.","journal-title":"Integr Biol (Camb)"},{"key":"1144_CR21","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/cvr\/cvz135","volume":"115","author":"T Katsimichas","year":"2019","unstructured":"Katsimichas T, Antonopoulos AS, Katsimichas A, Ohtani T, Sakata Y, Tousoulis D. The intestinal microbiota and cardiovascular disease. Cardiovasc Res. 2019;115:1471\u201386. https:\/\/doi.org\/10.1093\/cvr\/cvz135.","journal-title":"Cardiovasc Res."},{"key":"1144_CR22","doi-asserted-by":"publisher","unstructured":"\u2022 Leustean AM, Ciocoiu M, Sava A, Costea CF, Floria M, Tarniceriu CC, et al. Implications of the intestinal microbiota in diagnosing the progression of diabetes and the presence of cardiovascular complications. J Diabetes Res. 2018;2018:5205126. https:\/\/doi.org\/10.1155\/2018\/5205126. The data from this paper releveals implications of the intestinal microbiota in diagnosis the progression of diabetes and the presence of cardiovascular complications.","DOI":"10.1155\/2018\/5205126"},{"key":"1144_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576\u201385. https:\/\/doi.org\/10.1038\/nm.3145.","journal-title":"Nat Med."},{"key":"1144_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/cvr\/cvaa339","volume":"117","author":"TF L\u00fcscher","year":"2021","unstructured":"L\u00fcscher TF. They eat, what we eat, they digest, what we ingest: the microbiome and the vulnerable plaque. Cardiovasc Res. 2021;117:333\u20135. https:\/\/doi.org\/10.1093\/cvr\/cvaa339.","journal-title":"Cardiovasc Res."},{"key":"1144_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/17446651.2020.1720511","volume":"15","author":"MV Warmbrunn","year":"2020","unstructured":"Warmbrunn MV, Herrema H, Aron-Wisnewsky J, Soeters MR, Van Raalte DH, Nieuwdorp M. Gut microbiota: a promising target against cardiometabolic diseases. Expert Rev Endocrinol Metab. 2020;15:13\u201327. https:\/\/doi.org\/10.1080\/17446651.2020.1720511.","journal-title":"Expert Rev Endocrinol Metab."},{"key":"1144_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/09637486.2017.1343286","volume":"69","author":"FG C\u00e2ndido","year":"2018","unstructured":"C\u00e2ndido FG, Valente FX, Grze\u015bkowiak \u0141M, Moreira APB, Rocha DMUP, Alfenas RCG. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. Int J Food Sci Nutr. 2018;69:125\u201343. https:\/\/doi.org\/10.1080\/09637486.2017.1343286.","journal-title":"Int J Food Sci Nutr."},{"key":"1144_CR27","doi-asserted-by":"publisher","unstructured":"\u2022 De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol. 2014;592:2989\u201397. https:\/\/doi.org\/10.1113\/jphysiol.2014.273995. This paper suggest the role of microbiota-gut-brain axis in gastrointestinal disorders.","DOI":"10.1113\/jphysiol.2014.273995"},{"key":"1144_CR28","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","volume":"148","author":"JC Clemente","year":"2012","unstructured":"Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148:1258\u201370. https:\/\/doi.org\/10.1016\/j.cell.2012.01.035.","journal-title":"Cell."},{"key":"1144_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1469-0691.12172","volume":"19","author":"M Million","year":"2013","unstructured":"Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect. 2013;19:305\u201313. https:\/\/doi.org\/10.1111\/1469-0691.12172.","journal-title":"Clin Microbiol Infect."},{"key":"1144_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/MOL.0b013e3283347ebb","volume":"21","author":"G Musso","year":"2010","unstructured":"Musso G, Gambino R, Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol. 2010;21:76\u201383. https:\/\/doi.org\/10.1097\/MOL.0b013e3283347ebb.","journal-title":"Curr Opin Lipidol."},{"key":"1144_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12944-016-0278-4","volume":"15","author":"OA Baothman","year":"2016","unstructured":"Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis. 2016;15:108. https:\/\/doi.org\/10.1186\/s12944-016-0278-4.","journal-title":"Lipids Health Dis."},{"key":"1144_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbi.2010.10.023","volume":"25","author":"MT Bailey","year":"2011","unstructured":"Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun. 2011;25:397\u2013407. https:\/\/doi.org\/10.1016\/j.bbi.2010.10.023.","journal-title":"Brain Behav Immun."},{"key":"1144_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.psyneuen.2015.10.001","volume":"63","author":"A Bharwani","year":"2016","unstructured":"Bharwani A, Mian MF, Foster JA, Surette MG, Bienenstock J, Forsythe P. Structural & functional consequences of chronic psychosocial stress on the microbiome & host. Psychoneuroendocrinology. 2016;63:217\u201327. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.10.001.","journal-title":"Psychoneuroendocrinology."},{"key":"1144_CR34","doi-asserted-by":"publisher","unstructured":"Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The microbiome and Iirritable bowel syndrome - A review on the pathophysiology, Current research and future therapy. front microbiol. 2019;10:1136. https:\/\/doi.org\/10.3389\/fmicb.2019.01136.","DOI":"10.3389\/fmicb.2019.01136"},{"key":"1144_CR35","doi-asserted-by":"publisher","unstructured":"Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186\u201394. https:\/\/doi.org\/10.1016\/j.bbi.2015.03.016","DOI":"10.1016\/j.bbi.2015.03.016"},{"key":"1144_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4161\/gmic.21009","volume":"3","author":"S Maccaferri","year":"2012","unstructured":"Maccaferri S, Candela M, Turroni S, Centanni M, Severgnini M, Consolandi C, et al. IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation. Gut Microbes. 2012;3:406\u201313. https:\/\/doi.org\/10.4161\/gmic.21009.","journal-title":"Gut Microbes."},{"key":"1144_CR37","doi-asserted-by":"publisher","unstructured":"Hu S, Li A, Huang T, Lai J, Li J, Sublette ME, et al. Gut Microbiota changes in patients with bipolar depression. Adv Sci (Weinh). 2019;6:1900752. https:\/\/doi.org\/10.1002\/advs.201900752.","DOI":"10.1002\/advs.201900752"},{"key":"1144_CR38","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Toral M, Robles-Vera I, de la Visitaci\u00f3n N, Romero M, Yang T, S\u00e1nchez M, et al. Critical role of the interaction gut microbiota - sympathetic nervous system in the regulation of blood pressure. Front Physiol. 2019;10:231. https:\/\/doi.org\/10.3389\/fphys.2019.00231. This paper describes the role of the interaction gut microbiota and sympathetic nervous syetm in the regulation of blood pressure.","DOI":"10.3389\/fphys.2019.00231"},{"key":"1144_CR39","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.116.07910","volume":"68","author":"LF Gomez-Arango","year":"2016","unstructured":"Gomez-Arango LF, Barrett HL, McIntyre HD, Callaway LK, Morrison M, Dekker Nitert M. SPRING Trial Group. Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy. Hypertension. 2016;68:974\u201381. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07910.","journal-title":"Hypertension."},{"key":"1144_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8:845. https:\/\/doi.org\/10.1038\/s41467-017-00900-1.","journal-title":"Nat Commun."},{"key":"1144_CR41","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3389\/fmicb.2017.01936","volume":"8","author":"L Sanchez-Alcoholado","year":"2017","unstructured":"Sanchez-Alcoholado L, Castellano-Castillo D, Jord\u00e1n-Mart\u00ednez L, Moreno-Indias I, Cardila-Cruz P, Elena D, et al. Role of gut microbiota on cardio-metabolic parameters and immunity in coronary artery disease patients with and without type-2 diabetes mellitus. Front Microbiol. 2017;8:1936. https:\/\/doi.org\/10.3389\/fmicb.2017.01936.","journal-title":"Front Microbiol."},{"key":"1144_CR42","doi-asserted-by":"publisher","first-page":"e0174099","DOI":"10.1371\/journal.pone.0174099","volume":"12","author":"T Kamo","year":"2017","unstructured":"Kamo T, Akazawa H, Suda W, Saga-Kamo A, Shimizu Y, Yagi H, et al. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS One. 2017;12:e0174099. https:\/\/doi.org\/10.1371\/journal.pone.0174099.","journal-title":"PLoS One."},{"key":"1144_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.phrs.2017.06.015","volume":"123","author":"DP Singh","year":"2017","unstructured":"Singh DP, Singh J, Boparai RK, Zhu J, Mantri S, Khare P, et al. Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice. Pharmacol Res. 2017;123:103\u201313. https:\/\/doi.org\/10.1016\/j.phrs.2017.06.015.","journal-title":"Pharmacol Res."},{"key":"1144_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0035-1569330","volume":"124","author":"M Dambrova","year":"2016","unstructured":"Dambrova M, Latkovskis G, Kuka J, Strele I, Konrade I, Grinberga S, et al. Diabetes is associated with higher trimethylamine N-oxide plasma levels. Exp Clin Endocrinol Diabetes. 2016;124:251\u20136. https:\/\/doi.org\/10.1055\/s-0035-1569330.","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"1144_CR45","doi-asserted-by":"publisher","first-page":"e12920","DOI":"10.1111\/jsr.12920","volume":"29","author":"S El Aidy","year":"2019","unstructured":"El Aidy S, Bolsius YG, Raven F, Havekes R. A brief period of sleep deprivation leads to subtle changes in mouse gut microbiota. J Sleep Res. 2019;29:e12920. https:\/\/doi.org\/10.1111\/jsr.12920.","journal-title":"J Sleep Res."},{"key":"1144_CR46","doi-asserted-by":"publisher","unstructured":"\u2022 Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65:1331\u201340. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05315. This paper suggest the role of gut dysbiosis in the pathogenesis of hypertension.","DOI":"10.1161\/HYPERTENSIONAHA.115.05315"},{"key":"1144_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.psyneuen.2015.06.002","volume":"60","author":"AV Golubeva","year":"2015","unstructured":"Golubeva AV, Crampton S, Desbonnet L, Edge D, O\u2019Sullivan O, Lomasney KW, et al. Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood. Psychoneuroendocrinology. 2015;60:58\u201374. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.06.002.","journal-title":"Psychoneuroendocrinology."},{"key":"1144_CR48","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal Inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163:1585\u201395. https:\/\/doi.org\/10.1016\/j.cell.2015.11.055.","journal-title":"Cell."},{"key":"1144_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ehf2.12155","volume":"4","author":"M Luedde","year":"2017","unstructured":"Luedde M, Winkler T, Heinsen FA, R\u00fchlemann MC, Spehlmann ME, Bajrovic A, et al. Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Fail. 2017;4:282\u201390. https:\/\/doi.org\/10.1002\/ehf2.12155.","journal-title":"ESC Heart Fail."},{"key":"1144_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41598-017-18756-2","volume":"8","author":"X Cui","year":"2018","unstructured":"Cui X, Ye L, Li J, Jin L, Wang W, Li S, et al. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Sci Rep. 2018;8:635. https:\/\/doi.org\/10.1038\/s41598-017-18756-2.","journal-title":"Sci Rep."},{"key":"1144_CR51","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ncomms2266","volume":"3","author":"FH Karlsson","year":"2012","unstructured":"Karlsson FH, F\u00e5k F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245. https:\/\/doi.org\/10.1038\/ncomms2266.","journal-title":"Nat Commun."},{"key":"1144_CR52","doi-asserted-by":"publisher","unstructured":"Jeffery IB, O\u2019Toole PW, \u00d6hman L, Claesson MJ, Deane J, Quigley EM, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61:997\u20131006. https:\/\/doi.org\/10.1136\/gutjnl-2011-301501.","DOI":"10.1136\/gutjnl-2011-301501"},{"key":"1144_CR53","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3389\/fnins.2019.01226","volume":"13","author":"LP Morera","year":"2019","unstructured":"Morera LP, Marchiori GN, Medrano LA, Defag\u00f3 MD. Stress, dietary patterns and cardiovascular disease: a mini-review. Front Neurosci. 2019;13:1226. https:\/\/doi.org\/10.3389\/fnins.2019.01226.","journal-title":"Front Neurosci."},{"key":"1144_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000496183","volume":"12","author":"D Durrer Schutz","year":"2019","unstructured":"Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H, et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. 2019;12:40\u201366. https:\/\/doi.org\/10.1159\/000496183.","journal-title":"Obes Facts."},{"key":"1144_CR55","doi-asserted-by":"publisher","unstructured":"Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al. Obesity Management Task Force of the European Association for the Study of Obesity. European guidelines for obesity management in adults. Obes Facts. 2015;8:402\u201324. https:\/\/doi.org\/10.1159\/000442721.","DOI":"10.1159\/000442721"},{"key":"1144_CR56","unstructured":"Weir CB, Jan A. BMI classification percentile and cut off points. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. https:\/\/www-1ncbi-1nlm-1nih-1gov-100001ati0892.han3.wum.edu.pl\/books\/NBK541070\/Accessed Jan. 2020 Jul 10."},{"key":"1144_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert","year":"2004","unstructured":"Expert WHO. Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3.","journal-title":"Lancet."},{"key":"1144_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/kjm2.12010","volume":"35","author":"CS Chang","year":"2019","unstructured":"Chang CS, Ruan JW, Kao CY. An overview of microbiome based strategies on anti-obesity. Kaohsiung J Med Sci. 2019;35:7\u201316. https:\/\/doi.org\/10.1002\/kjm2.12010.","journal-title":"Kaohsiung J Med Sci."},{"key":"1144_CR59","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1038\/s41467-019-11370-y","volume":"10","author":"H Luck","year":"2019","unstructured":"Luck H, Khan S, Kim JH, Copeland JK, Revelo XS, Tsai S, et al. Gut-associated IgA + immune cells regulate obesity-related insulin resistance. Nat Commun. 2019;10:3650. https:\/\/doi.org\/10.1038\/s41467-019-11370-y.","journal-title":"Nat Commun."},{"key":"1144_CR60","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0140-6736(16)31714-7","volume":"389","author":"A Tawakol","year":"2017","unstructured":"Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. 2017;389:834\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(16)31714-7.","journal-title":"Lancet."},{"key":"1144_CR61","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","volume":"11","author":"KT Vel\u00e1zquez","year":"2019","unstructured":"Vel\u00e1zquez KT, Enos RT, Bader JE, Sougiannis AT, Carson MS, Chatzistamou I, et al. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World J Hepatol. 2019;11:619\u201337. https:\/\/doi.org\/10.4254\/wjh.v11.i8.619.","journal-title":"World J Hepatol."},{"key":"1144_CR62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cmet.2015.06.001","volume":"22","author":"L Garidou","year":"2015","unstructured":"Garidou L, Pomi\u00e9 C, Klopp P, Waget A, Charpentier J, Aloulou M, et al. The gut microbiota regulates intestinal CD4 T cells expressing ROR\u03b3t and controls metabolic disease. Cell Metab. 2015;22:100\u201312. https:\/\/doi.org\/10.1016\/j.cmet.2015.06.001.","journal-title":"Cell Metab."},{"key":"1144_CR63","doi-asserted-by":"publisher","first-page":"13424","DOI":"10.1038\/s41598-019-49462-w","volume":"9","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, Li D, He Y, Li Y, Yang Z, Zhao X, et al. Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities. Sci Rep. 2019;9:13424. https:\/\/doi.org\/10.1038\/s41598-019-49462-w.","journal-title":"Sci Rep."},{"key":"1144_CR64","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022\u20133. https:\/\/doi.org\/10.1038\/4441022a.","journal-title":"Nature."},{"key":"1144_CR65","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/nu11112690","volume":"11","author":"L Abenavoli","year":"2019","unstructured":"Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, et al. Gut microbiota and obesity: a role for probiotics. Nutrients. 2019;11:2690. https:\/\/doi.org\/10.3390\/nu11112690.","journal-title":"Nutrients."},{"key":"1144_CR66","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/nu11030635","volume":"11","author":"T Cerd\u00f3","year":"2019","unstructured":"Cerd\u00f3 T, Garc\u00eda-Santos JA, Berm\u00fadez MG, Campoy C. The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients. 2019;11:635. https:\/\/doi.org\/10.3390\/nu11030635.","journal-title":"Nutrients."},{"key":"1144_CR67","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/apt.12758","volume":"39","author":"A Alisi","year":"2014","unstructured":"Alisi A, Bedogni G, Baviera G, Giorgio V, Porro E, Paris C, et al. Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2014;39:1276\u201385. https:\/\/doi.org\/10.1111\/apt.12758.","journal-title":"Aliment Pharmacol Ther."},{"key":"1144_CR68","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s00394-018-1828-5","volume":"58","author":"J Sanchis-Chord\u00e0","year":"2019","unstructured":"Sanchis-Chord\u00e0 J, Del Pulgar EMG, Carrasco-Luna J, Ben\u00edtez-P\u00e1ez A, Sanz Y, Codo\u00f1er-Franch P. Bifidobacterium pseudocatenulatum CECT 7765 supplementation improves inflammatory status in insulin-resistant obese children. Eur J Nutr. 2019;58:2789\u2013800. https:\/\/doi.org\/10.1007\/s00394-018-1828-5.","journal-title":"Eur J Nutr."},{"key":"1144_CR69","doi-asserted-by":"publisher","unstructured":"Jones RB, Alderete TL, Martin AA, Geary BA, Hwang DH, Palmer SL, et al. Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial. Pediatr Obes. 2018;13:705\u201314. https:\/\/doi.org\/10.1111\/ijpo.12273.","DOI":"10.1111\/ijpo.12273"},{"key":"1144_CR70","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/oby.21671","volume":"25","author":"AC Gomes","year":"2017","unstructured":"Gomes AC, de Sousa RG, Botelho PB, Gomes TL, Prada PO, Mota JF. The additional effects of a probiotic mix on abdominal adiposity and antioxidant status: a double-blind, randomized trial. Obesity (Silver Spring). 2017;25:30\u20138. https:\/\/doi.org\/10.1002\/oby.21671.","journal-title":"Obesity (Silver Spring)"},{"key":"1144_CR71","doi-asserted-by":"publisher","unstructured":"Higashikawa F, Noda M, Awaya T, Danshiitsoodol N, Matoba Y, Kumagai T, et al. Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial. Eur J Clin Nutr. 2016;70:582\u20137. https:\/\/doi.org\/10.1038\/ejcn.2016.17.","DOI":"10.1038\/ejcn.2016.17"},{"key":"1144_CR72","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1089\/jmf.2017.3937","volume":"21","author":"J Kim","year":"2018","unstructured":"Kim J, Yun JM, Kim MK, Kwon O, Cho B. Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: a randomized, double-blind, placebo-controlled trial. J Med Food. 2018;21:454\u201361. https:\/\/doi.org\/10.1089\/jmf.2017.3937.","journal-title":"J Med Food."},{"key":"1144_CR73","doi-asserted-by":"publisher","unstructured":"Minami J, Iwabuchi N, Tanaka M, Yamauchi K, Xiao JZ, Abe F, et al. Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial. Biosci Microbiota Food Health. 2018;37:67\u201375. https:\/\/doi.org\/10.12938\/bmfh.18-001.","DOI":"10.12938\/bmfh.18-001"},{"key":"1144_CR74","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/s41366-018-0220-0","volume":"43","author":"A Pedret","year":"2019","unstructured":"Pedret A, Valls RM, Calder\u00f3n-P\u00e9rez L, Llaurad\u00f3 E, Companys J, Pla-Pag\u00e0 L, et al. Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial. Int J Obes (Lond). 2019;43:1863\u20138. https:\/\/doi.org\/10.1038\/s41366-018-0220-0.","journal-title":"Int J Obes (Lond)"},{"key":"1144_CR75","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/obr.12626","volume":"19","author":"H Borgeraas","year":"2018","unstructured":"Borgeraas H, Johnson LK, Skattebu J, Hertel JK, Hjelmesaeth J. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2018;19:219\u201332. https:\/\/doi.org\/10.1111\/obr.12626.","journal-title":"Obes Rev."},{"key":"1144_CR76","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/nu9030284","volume":"9","author":"M Sanchez","year":"2017","unstructured":"Sanchez M, Darimont C, Panahi S, Drapeau V, Marette A, Taylor VH, et al. Effects of a diet-based weight-reducing program with probiotic supplementation on satiety efficiency, eating behaviour traits, and psychosocial behaviours in obese individuals. Nutrients. 2017;9:284. https:\/\/doi.org\/10.3390\/nu9030284.","journal-title":"Nutrients."},{"key":"1144_CR77","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/13651501.2017.1417442","volume":"22","author":"IG Anghelescu","year":"2018","unstructured":"Anghelescu IG, Edwards D, Seifritz E, Kasper S. Stress management and the role of Rhodiola rosea: a review. Int J Psychiatry Clin Pract. 2018;22:242\u201352. https:\/\/doi.org\/10.1080\/13651501.2017.1417442.","journal-title":"Int J Psychiatry Clin Pract."},{"key":"1144_CR78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00401-013-1223-5","volume":"127","author":"PJ Lucassen","year":"2014","unstructured":"Lucassen PJ, Pruessner J, Sousa N, Almeida OF, Van Dam AM, Rajkowska G, et al. Neuropathology of stress. Acta Neuropathol. 2014;127:109\u20131035. https:\/\/doi.org\/10.1007\/s00401-013-1223-5.","journal-title":"Acta Neuropathol."},{"key":"1144_CR79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00441-010-1050-0","volume":"343","author":"M Lyte","year":"2011","unstructured":"Lyte M, Vulchanova L, Brown DR. Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res. 2011;343:23\u201332. https:\/\/doi.org\/10.1007\/s00441-010-1050-0.","journal-title":"Cell Tissue Res."},{"key":"1144_CR80","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fendo.2019.00504","volume":"10","author":"N Sudo","year":"2019","unstructured":"Sudo N. Biogenic Amines: signals between commensal microbiota and gut physiology. Front Endocrinol (Lausanne). 2019;10:504. https:\/\/doi.org\/10.3389\/fendo.2019.00504.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1144_CR81","doi-asserted-by":"publisher","unstructured":"Park AJ, Collins J, Blennerhassett PA, Ghia JE, Verdu EF, Bercik P, et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil. 2013;25:733\u2013e575. https:\/\/doi.org\/10.1111\/nmo.12153.","DOI":"10.1111\/nmo.12153"},{"key":"1144_CR82","doi-asserted-by":"publisher","first-page":"10776","DOI":"10.1038\/s41598-017-11069-4","volume":"7","author":"LC Bridgewater","year":"2017","unstructured":"Bridgewater LC, Zhang C, Wu Y, Hu W, Zhang Q, Wang J, et al. Gender-based differences in host behavior and gut microbiota composition in response to high fat diet and stress in a mouse model. Sci Rep. 2017;7:10776. https:\/\/doi.org\/10.1038\/s41598-017-11069-4.","journal-title":"Sci Rep."},{"key":"1144_CR83","doi-asserted-by":"publisher","first-page":"100216","DOI":"10.1016\/j.ynstr.2020.100216","volume":"12","author":"P Tian","year":"2020","unstructured":"Tian P, O\u2019Riordan KJ, Lee YK, Wang G, Zhao J, Zhang H, et al. Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiol Stress. 2020;12:100216. https:\/\/doi.org\/10.1016\/j.ynstr.2020.100216.","journal-title":"Neurobiol Stress."},{"key":"1144_CR84","doi-asserted-by":"publisher","first-page":"G1228","DOI":"10.1152\/ajpgi.00358.2006","volume":"292","author":"G Boudry","year":"2007","unstructured":"Boudry G, Jury J, Yang PC, Perdue MH. Chronic psychological stress alters epithelial cell turn-over in rat ileum. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1228\u201332. https:\/\/doi.org\/10.1152\/ajpgi.00358.2006.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"1144_CR85","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/MIB.0b013e3182802a4e","volume":"19","author":"EM Lennon","year":"2013","unstructured":"Lennon EM, Maharshak N, Elloumi H, Borst L, Plevy SE, Moeser AJ. Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-\/- mice. Inflamm Bowel Dis. 2013;19:712\u20139. https:\/\/doi.org\/10.1097\/MIB.0b013e3182802a4e.","journal-title":"Inflamm Bowel Dis."},{"key":"1144_CR86","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-230X-10-134","volume":"10","author":"SO Noor","year":"2010","unstructured":"Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134. https:\/\/doi.org\/10.1186\/1471-230X-10-134.","journal-title":"BMC Gastroenterol."},{"key":"1144_CR87","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC Scientific Document Group. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","journal-title":"Eur Heart J."},{"key":"1144_CR88","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","volume":"135","author":"FZ Marques","year":"2017","unstructured":"Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135:964\u201397. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024545.","journal-title":"Circulation."},{"key":"1144_CR89","doi-asserted-by":"publisher","unstructured":"\u2022 O\u2019Donovan AN, Herisson FM, Fouhy F, Ryan PM, Whelan D, Johnson CN, et al. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. Am J Physiol Heart Circ Physiol. 2020;318:H590\u2013603. https:\/\/doi.org\/10.1152\/ajpheart.00512.2019. The data from this paper reveals the role of gut microbiom in the development of metabolic syndrom and chronic heart failure.","DOI":"10.1152\/ajpheart.00512.2019"},{"key":"1144_CR90","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.116.307709","volume":"118","author":"MM Santisteban","year":"2016","unstructured":"Santisteban MM, Kim S, Pepine CJ, Raizada MK. Brain-gut-bone marrow axis: implications for hypertension and related therapeutics. Circ Res. 2016;118:1327\u201336. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307709.","journal-title":"Circ Res."},{"key":"1144_CR91","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/CIRCRESAHA.117.305853","volume":"117","author":"MM Santisteban","year":"2015","unstructured":"Santisteban MM, Ahmari N, Carvajal JM, Zingler MB, Qi Y, Kim S, et al. Involvement of bone marrow cells and neuroinflammation in hypertension. Circ Res. 2015;117:178\u201391. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.305853.","journal-title":"Circ Res."},{"key":"1144_CR92","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3389\/fimmu.2018.02031","volume":"9","author":"M Fioranelli","year":"2018","unstructured":"Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol. 2018;9:2031. https:\/\/doi.org\/10.3389\/fimmu.2018.02031.","journal-title":"Front Immunol."},{"key":"1144_CR93","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/eurheartj\/ehw480","volume":"38","author":"U Landmesser","year":"2017","unstructured":"Landmesser U, Chapman MJ, Farnier M, Gencer B, Gielen S, Hovingh GK, et al. European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). European Society of Cardiology\/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin\/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk. Eur Heart J. 2017;38:2245\u201355. https:\/\/doi.org\/10.1093\/eurheartj\/ehw480.","journal-title":"Eur Heart J."},{"key":"1144_CR94","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1194\/jlr.M072165","volume":"58","author":"K Kasahara","year":"2017","unstructured":"Kasahara K, Tanoue T, Yamashita T, Yodoi K, Matsumoto T, Emoto T, et al. Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis. J Lipid Res. 2017;58:519\u201328. https:\/\/doi.org\/10.1194\/jlr.M072165.","journal-title":"J Lipid Res."},{"key":"1144_CR95","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57\u201363. https:\/\/doi.org\/10.1038\/nature09922.","journal-title":"Nature."},{"key":"1144_CR96","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","volume":"133","author":"J Li","year":"2016","unstructured":"Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-\/- mice. Circulation. 2016;133:2434\u201346. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019645.","journal-title":"Circulation."},{"key":"1144_CR97","doi-asserted-by":"publisher","unstructured":"\u2022 Caesar R, F\u00e5k F, B\u00e4ckhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med. 2010;268:320\u20138. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02270.x. This paper suggest the role of gut microbiota in the pathogenesis of the atherosclerosis.","DOI":"10.1111\/j.1365-2796.2010.02270.x"},{"key":"1144_CR98","doi-asserted-by":"publisher","first-page":"3863726","DOI":"10.1155\/2016\/3863726","volume":"2016","author":"C Csonka","year":"2016","unstructured":"Csonka C, S\u00e1rk\u00f6zy M, Pipicz M, Dux L, Csont T. Modulation of hypercholesterolemia-induced oxidative\/nitrative stress in the heart. Oxid Med Cell Longev. 2016;2016:3863726. https:\/\/doi.org\/10.1155\/2016\/3863726.","journal-title":"Oxid Med Cell Longev."},{"key":"1144_CR99","doi-asserted-by":"publisher","unstructured":"Chen L, Ishigami T, Nakashima-Sasaki R, Kino T, Doi H, Minegishi S, et al. Commensal microbe-specific activation of B2 cell subsets contributes to atherosclerosis development independently of lipid metabolism. EBioMedicine. 2016;13:237\u201347. https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.030.","DOI":"10.1016\/j.ebiom.2016.10.030"},{"key":"1144_CR100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12974-020-1705-z","volume":"17","author":"S Zhu","year":"2020","unstructured":"Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, et al. The progress of gut microbiome research related to brain disorders. J Neuroinflammation. 2020;17:25. https:\/\/doi.org\/10.1186\/s12974-020-1705-z.","journal-title":"J Neuroinflammation."},{"key":"1144_CR101","first-page":"117","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008;29:117\u201324.","journal-title":"Neuro Endocrinol Lett."},{"key":"1144_CR102","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","journal-title":"Eur Heart J."},{"key":"1144_CR103","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11906-020-01046-0","volume":"22","author":"Y Sata","year":"2020","unstructured":"Sata Y, Marques FZ, Kaye DM. The emerging role of gut dysbiosis in cardio-metabolic risk factors for heart failure. Curr Hypertens Rep. 2020;22:38. https:\/\/doi.org\/10.1007\/s11906-020-01046-0.","journal-title":"Curr Hypertens Rep."},{"key":"1144_CR104","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.ebiom.2020.102649","volume":"52","author":"M Tr\u00f8seid","year":"2020","unstructured":"Tr\u00f8seid M, Andersen G\u00d8, Broch K, Hov JR. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine. 2020;52:102649. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102649.","journal-title":"EBioMedicine."},{"key":"1144_CR105","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/joim.12328","volume":"277","author":"M Tr\u00f8seid","year":"2015","unstructured":"Tr\u00f8seid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med. 2015;277:717\u201326. https:\/\/doi.org\/10.1111\/joim.12328.","journal-title":"J Intern Med."},{"key":"1144_CR106","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/heartjnl-2015-308826","volume":"102","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Heaney LM, Bhandari SS, Jones DJ, Ng LL. Trimethylamine N-oxide and prognosis in acute heart failure. Heart. 2016;102:841\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2015-308826.","journal-title":"Heart."},{"key":"1144_CR107","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WH Tang","year":"2014","unstructured":"Tang WH, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM, et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol. 2014;64:1908\u201314. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.617.","journal-title":"J Am Coll Cardiol."},{"key":"1144_CR108","doi-asserted-by":"publisher","unstructured":"\u2022 Battson ML, Lee DM, Li Puma LC, Ecton KE, Thomas KN, Febvre HP, et al. Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity. Am J Physiol Heart Circ Physiol. 2019;317:H1210\u201320. https:\/\/doi.org\/10.1152\/ajpheart.00346.2019. This paper suggest the role of gut microbiota in obesity and cardiovascular disease.","DOI":"10.1152\/ajpheart.00346.2019"},{"key":"1144_CR109","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.toxlet.2016.12.017","volume":"267","author":"M Makrecka-Kuka","year":"2017","unstructured":"Makrecka-Kuka M, Volska K, Antone U, Vilskersts R, Grinberga S, Bandere D, et al. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol Lett. 2017;267:32\u20138. https:\/\/doi.org\/10.1016\/j.toxlet.2016.12.017.","journal-title":"Toxicol Lett."},{"key":"1144_CR110","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.psyneuen.2012.03.007","volume":"37","author":"TG Dinan","year":"2012","unstructured":"Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology. 2012;37:1369\u201378. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.03.007.","journal-title":"Psychoneuroendocrinology."},{"key":"1144_CR111","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(07)61305-1","volume":"370","author":"DJ Brotman","year":"2007","unstructured":"Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007;370:1089\u2013100. https:\/\/doi.org\/10.1016\/S0140-6736(07)61305-1.","journal-title":"Lancet."},{"key":"1144_CR112","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/HRP.0000000000000162","volume":"26","author":"CM Celano","year":"2018","unstructured":"Celano CM, Villegas AC, Albanese AM, Gaggin HK, Huffman JC. Depression and anxiety in heart failure: a review. Harv Rev Psychiatry. 2018;26:175\u201384. https:\/\/doi.org\/10.1097\/HRP.0000000000000162.","journal-title":"Harv Rev Psychiatry."}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01144-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-021-01144-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01144-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T08:34:21Z","timestamp":1622709261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-021-01144-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s11906-021-01144-7","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"6 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"31"}}